---
title: "Cold and flu brands in Australia: Which are searched most?"
description: "Compare the cold, flu and sore throat remedy brands Australians reach for. Share of Search among Strepsils, Sudafed, Lemsip, Bisolvon, Codral, Demazin, Vicks, Difflam, Duro-Tuss and Nurofen, the cold and flu brands Brandwave compares in Australia, using the same methodology, market, and reporting period. Branded searches tell you how often people look for a brand by name or related terms. Comparing these searches across competitors helps you see how popular each brand is over time."
canonical: "https://gobrandwave.com/demand/au/categories/au-cold-and-flu-brands"
publisher: "Brandwave"
---

# Cold and flu brands in Australia: Which are searched most?

Compare the cold, flu and sore throat remedy brands Australians reach for. Share of Search among Strepsils, Sudafed, Lemsip, Bisolvon, Codral, Demazin, Vicks, Difflam, Duro-Tuss and Nurofen, the cold and flu brands Brandwave compares in Australia, using the same methodology, market, and reporting period. Branded searches tell you how often people look for a brand by name or related terms. Comparing these searches across competitors helps you see how popular each brand is over time.

## Key facts

- **Competitive set**: Cold and flu brands
- **Market**: Australia
- **Brands compared**: 10
- **Month measured**: Sep 2026
- **Highest Share of Search**: Strepsils, 17%

## Which brand is most popular in search among cold and flu brands in Australia?

- Strepsils and Sudafed tie for the highest share of searches among cold and flu brands in Australia, at 17% each in September 2026.
- Across the 12 months ending September 2026, Strepsils’ share of searches among cold and flu brands in Australia increased from 16.2% to 17%.
- Across the 12 months ending September 2026, Sudafed’s share of searches among cold and flu brands in Australia decreased from 19.8% to 17%.
- Across the 12 months ending September 2026, Lemsip’s share of searches among cold and flu brands in Australia increased from 10.8% to 13.9%.
- Across the 12 months ending September 2026, Bisolvon’s share of searches among cold and flu brands in Australia decreased from 10.8% to 9.3%.
- Across the 12 months ending September 2026, Demazin’s share of searches among cold and flu brands in Australia decreased from 10.8% to 9.3%.
- Across the 12 months ending September 2026, Vicks’ share of searches among cold and flu brands in Australia increased from 5.9% to 7.6%.
- Across the 12 months ending September 2026, Difflam’s share of searches among cold and flu brands in Australia decreased from 7.2% to 6.2%.
- Across the 12 months ending September 2026, Strepsils’ share of searches among cold and flu brands in Australia peaked at 17.2% in November 2025 and was lowest at 14.7% in June 2026.
- Across the 12 months ending September 2026, Sudafed’s share of searches among cold and flu brands in Australia peaked at 23.3% in December 2025 and was lowest at 17% in September 2026.
- Across the 12 months ending September 2026, Lemsip’s share of searches among cold and flu brands in Australia peaked at 15.8% in May 2026 and was lowest at 10.4% in December 2025.
- Across the 12 months ending September 2026, Bisolvon’s share of searches among cold and flu brands in Australia peaked at 11.1% in February 2026 and was lowest at 8.7% in May 2026.
- Across the 12 months ending September 2026, Codral’s share of searches among cold and flu brands in Australia peaked at 9.9% in June 2026 and was lowest at 7.7% in November 2025.
- Across the 12 months ending September 2026, Demazin’s share of searches among cold and flu brands in Australia peaked at 10.8% in October 2025 and was lowest at 7.1% in May 2026.
- Across the 12 months ending September 2026, Vicks’ share of searches among cold and flu brands in Australia peaked at 8.7% in May 2026 and was lowest at 5.9% in October 2025.
- Across the 12 months ending September 2026, Difflam’s share of searches among cold and flu brands in Australia peaked at 7.7% in November 2025 and was lowest at 6.1% in July 2026.
- Across the 12 months ending September 2026, Duro-Tuss’ share of searches among cold and flu brands in Australia peaked at 6.6% in June 2026 and was lowest at 4.9% in February 2026.
- Across the 12 months ending September 2026, Nurofen’s share of searches among cold and flu brands in Australia peaked at 4.1% in September 2026 and was lowest at 3.1% in May 2026.
- Across the 12 months ending September 2026, Strepsils rose from 2nd to 1st among cold and flu brands in Australia.
- Across the 12 months ending September 2026, Sudafed fell from 1st to 2nd among cold and flu brands in Australia.
- Across the 12 months ending September 2026, Lemsip rose from 5th to 3rd among cold and flu brands in Australia.
- Across the 12 months ending September 2026, Bisolvon fell from 3rd to 4th among cold and flu brands in Australia.
- Across the 12 months ending September 2026, Codral rose from 6th to 5th among cold and flu brands in Australia.
- Across the 12 months ending September 2026, Demazin fell from 4th to 6th among cold and flu brands in Australia.
- Across the 12 months ending September 2026, Vicks rose from 9th to 7th among cold and flu brands in Australia.
- Across the 12 months ending September 2026, Difflam fell from 7th to 8th among cold and flu brands in Australia.
- Across the 12 months ending September 2026, Duro-Tuss fell from 8th to 9th among cold and flu brands in Australia.
- Across the 12 months ending September 2026, Nurofen held steady: its share of searches among cold and flu brands in Australia moved less than 0.5 percentage points.

## Top cold and flu brands in ChatGPT and Google AI Overviews

In Brandwave's three ChatGPT questions and two Google AI Overviews, Nurofen was mentioned most often, in three of the five answers. Strepsils, which ranked first in searches, was not mentioned at all.

Too few answers listed options to rank the brands, so only mentions are counted.

| Brand | ChatGPT answers that named it | Google AI Overviews that named it | All answers that named it |
| --- | --- | --- | --- |
| Strepsils | 0 of 3 | 0 of 2 | 0 of 5 |
| Sudafed | 0 of 3 | 0 of 2 | 0 of 5 |
| Lemsip | 0 of 3 | 0 of 2 | 0 of 5 |
| Bisolvon | 0 of 3 | 0 of 2 | 0 of 5 |
| Codral | 1 of 3 | 1 of 2 | 2 of 5 |
| Demazin | 1 of 3 | 0 of 2 | 1 of 5 |
| Vicks | 0 of 3 | 0 of 2 | 0 of 5 |
| Difflam | 0 of 3 | 0 of 2 | 0 of 5 |
| Duro-Tuss | 0 of 3 | 0 of 2 | 0 of 5 |
| Nurofen | 2 of 3 | 1 of 2 | 3 of 5 |

## Every AI answer about cold and flu brands

- Asked ChatGPT "What should I take for a cold in Australia?": 1. Nurofen
- Asked ChatGPT "What are the best cold and flu tablets in Australia?": 1. Codral, 2. Demazin, 3. Nurofen
- Asked ChatGPT "What's the best thing for a sore throat?": named none of the brands we track
- Searched Google, AI Overview "cold and flu tablets": 1. Codral, 2. Nurofen
- Searched Google, AI Overview "sore throat": named none of the brands we track

Not named in any answer: Strepsils, Sudafed, Lemsip, Bisolvon, Vicks, Difflam and Duro-Tuss.

Brands are listed in the order each answer named them. The answers were collected in Australia on October 26, 2026.

## Compare search popularity between leading brands

- [Strepsils vs Sudafed: compare search popularity](/demand/au/compare/strepsils-vs-sudafed): 17% Share of Search each.
- [Strepsils vs Lemsip: compare search popularity](/demand/au/compare/lemsip-vs-strepsils): 17% against 13.9% Share of Search.
- [Strepsils vs Bisolvon: compare search popularity](/demand/au/compare/bisolvon-vs-strepsils): 17% against 9.3% Share of Search.
- [Strepsils vs Codral: compare search popularity](/demand/au/compare/codral-vs-strepsils): 17% against 9.3% Share of Search.
- [Sudafed vs Lemsip: compare search popularity](/demand/au/compare/lemsip-vs-sudafed): 17% against 13.9% Share of Search.
- [Sudafed vs Bisolvon: compare search popularity](/demand/au/compare/bisolvon-vs-sudafed): 17% against 9.3% Share of Search.
- [Sudafed vs Codral: compare search popularity](/demand/au/compare/codral-vs-sudafed): 17% against 9.3% Share of Search.
- [Lemsip vs Bisolvon: compare search popularity](/demand/au/compare/bisolvon-vs-lemsip): 13.9% against 9.3% Share of Search.
- [Lemsip vs Codral: compare search popularity](/demand/au/compare/codral-vs-lemsip): 13.9% against 9.3% Share of Search.
- [Bisolvon vs Codral: compare search popularity](/demand/au/compare/bisolvon-vs-codral): 9.3% Share of Search each.

## How did search popularity change for Australia cold and flu brands in September 2026?

- In September 2026, Strepsils overtook Sudafed to become the leader among cold and flu brands in Australia, with 17% of the searches.
- In September 2026, Demazin gained share of searches among cold and flu brands in Australia, from 7.4% to 9.3%.
- In September 2026, Sudafed lost share of searches among cold and flu brands in Australia, from 20.1% to 17%.
- In September 2026, Difflam lost share of searches among cold and flu brands in Australia, from 7.4% to 6.2%.
- In September 2026, Vicks rose from 8th to 7th among cold and flu brands in Australia.
- Estimated monthly branded searches for Lemsip in Australia rose 82.7% over 12 measured months, from 8.1K to 14.8K in September 2026.
- Estimated monthly branded searches for Nurofen in Australia rose 51.7% over 12 measured months, from 2.9K to 4.4K in September 2026.
- Estimated monthly branded searches for Codral in Australia rose 50% over 12 measured months, from 6.6K to 9.9K in September 2026.

## Share of Search ranking

| Rank | Brand | Share of Search | Estimated monthly branded searches | Change vs prior month | Owned by |
| --- | --- | --- | --- | --- | --- |
| 1 | Strepsils | 17% | 18.1K | 0.0% | Strepsils |
| 2 | Sudafed | 17% | 18.1K | -18.5% | Sudafed |
| 3 | Lemsip | 13.9% | 14.8K | 0.0% | Lemsip |
| 4 | Bisolvon | 9.3% | 9.9K | 0.0% | Bisolvon |
| 5 | Codral | 9.3% | 9.9K | 0.0% | Codral |
| 6 | Demazin | 9.3% | 9.9K | +22.2% | Demazin |
| 7 | Vicks | 7.6% | 8.1K | 0.0% | Vicks |
| 8 | Difflam | 6.2% | 6.6K | -18.5% | Difflam |
| 9 | Duro-Tuss | 6.2% | 6.6K | 0.0% | Duro-Tuss |
| 10 | Nurofen | 4.1% | 4.4K | 0.0% | Reckitt |

Nurofen sells other things too, so only its searches that name this product count here, like “nurofen cold and flu”.

## Historical estimated branded-search demand

| Month | Brand | Estimated monthly branded searches | Share of Search | Rank |
| --- | --- | --- | --- | --- |
| Oct 2025 | Sudafed | 14.8K | 19.8% | 1 |
| Oct 2025 | Strepsils | 12.1K | 16.2% | 2 |
| Oct 2025 | Bisolvon | 8.1K | 10.8% | 3 |
| Oct 2025 | Demazin | 8.1K | 10.8% | 4 |
| Oct 2025 | Lemsip | 8.1K | 10.8% | 5 |
| Oct 2025 | Codral | 6.6K | 8.8% | 6 |
| Oct 2025 | Difflam | 5.4K | 7.2% | 7 |
| Oct 2025 | Duro-Tuss | 4.4K | 5.9% | 8 |
| Oct 2025 | Vicks | 4.4K | 5.9% | 9 |
| Oct 2025 | Nurofen | 2.9K | 3.9% | 10 |
| Nov 2025 | Sudafed | 14.8K | 21.1% | 1 |
| Nov 2025 | Strepsils | 12.1K | 17.2% | 2 |
| Nov 2025 | Lemsip | 8.1K | 11.5% | 3 |
| Nov 2025 | Bisolvon | 6.6K | 9.4% | 4 |
| Nov 2025 | Demazin | 6.6K | 9.4% | 5 |
| Nov 2025 | Codral | 5.4K | 7.7% | 6 |
| Nov 2025 | Difflam | 5.4K | 7.7% | 7 |
| Nov 2025 | Duro-Tuss | 4.4K | 6.3% | 8 |
| Nov 2025 | Vicks | 4.4K | 6.3% | 9 |
| Nov 2025 | Nurofen | 2.4K | 3.4% | 10 |
| Dec 2025 | Sudafed | 14.8K | 23.3% | 1 |
| Dec 2025 | Strepsils | 9.9K | 15.6% | 2 |
| Dec 2025 | Bisolvon | 6.6K | 10.4% | 3 |
| Dec 2025 | Lemsip | 6.6K | 10.4% | 4 |
| Dec 2025 | Codral | 5.4K | 8.5% | 5 |
| Dec 2025 | Demazin | 5.4K | 8.5% | 6 |
| Dec 2025 | Difflam | 4.4K | 6.9% | 7 |
| Dec 2025 | Vicks | 4.4K | 6.9% | 8 |
| Dec 2025 | Duro-Tuss | 3.6K | 5.7% | 9 |
| Dec 2025 | Nurofen | 2.4K | 3.8% | 10 |
| Jan 2026 | Sudafed | 9.9K | 20.1% | 1 |
| Jan 2026 | Strepsils | 8.1K | 16.4% | 2 |
| Jan 2026 | Bisolvon | 5.4K | 11% | 3 |
| Jan 2026 | Lemsip | 5.4K | 11% | 4 |
| Jan 2026 | Codral | 4.4K | 8.9% | 5 |
| Jan 2026 | Demazin | 4.4K | 8.9% | 6 |
| Jan 2026 | Difflam | 3.6K | 7.3% | 7 |
| Jan 2026 | Vicks | 3.6K | 7.3% | 8 |
| Jan 2026 | Duro-Tuss | 2.9K | 5.9% | 9 |
| Jan 2026 | Nurofen | 1.6K | 3.2% | 10 |
| Feb 2026 | Sudafed | 9.9K | 20.3% | 1 |
| Feb 2026 | Strepsils | 8.1K | 16.6% | 2 |
| Feb 2026 | Bisolvon | 5.4K | 11.1% | 3 |
| Feb 2026 | Lemsip | 5.4K | 11.1% | 4 |
| Feb 2026 | Codral | 4.4K | 9% | 5 |
| Feb 2026 | Demazin | 4.4K | 9% | 6 |
| Feb 2026 | Difflam | 3.6K | 7.4% | 7 |
| Feb 2026 | Vicks | 3.6K | 7.4% | 8 |
| Feb 2026 | Duro-Tuss | 2.4K | 4.9% | 9 |
| Feb 2026 | Nurofen | 1.6K | 3.3% | 10 |
| Mar 2026 | Sudafed | 14.8K | 21% | 1 |
| Mar 2026 | Strepsils | 12.1K | 17.2% | 2 |
| Mar 2026 | Lemsip | 8.1K | 11.5% | 3 |
| Mar 2026 | Bisolvon | 6.6K | 9.4% | 4 |
| Mar 2026 | Codral | 6.6K | 9.4% | 5 |
| Mar 2026 | Demazin | 5.4K | 7.7% | 6 |
| Mar 2026 | Difflam | 5.4K | 7.7% | 7 |
| Mar 2026 | Vicks | 5.4K | 7.7% | 8 |
| Mar 2026 | Duro-Tuss | 3.6K | 5.1% | 9 |
| Mar 2026 | Nurofen | 2.4K | 3.4% | 10 |
| Apr 2026 | Sudafed | 14.8K | 20.3% | 1 |
| Apr 2026 | Strepsils | 12.1K | 16.6% | 2 |
| Apr 2026 | Lemsip | 9.9K | 13.6% | 3 |
| Apr 2026 | Bisolvon | 6.6K | 9% | 4 |
| Apr 2026 | Codral | 6.6K | 9% | 5 |
| Apr 2026 | Demazin | 5.4K | 7.4% | 6 |
| Apr 2026 | Difflam | 5.4K | 7.4% | 7 |
| Apr 2026 | Vicks | 5.4K | 7.4% | 8 |
| Apr 2026 | Duro-Tuss | 4.4K | 6% | 9 |
| Apr 2026 | Nurofen | 2.4K | 3.3% | 10 |
| May 2026 | Sudafed | 18.1K | 19.4% | 1 |
| May 2026 | Lemsip | 14.8K | 15.8% | 2 |
| May 2026 | Strepsils | 14.8K | 15.8% | 3 |
| May 2026 | Bisolvon | 8.1K | 8.7% | 4 |
| May 2026 | Codral | 8.1K | 8.7% | 5 |
| May 2026 | Vicks | 8.1K | 8.7% | 6 |
| May 2026 | Demazin | 6.6K | 7.1% | 7 |
| May 2026 | Difflam | 6.6K | 7.1% | 8 |
| May 2026 | Duro-Tuss | 5.4K | 5.8% | 9 |
| May 2026 | Nurofen | 2.9K | 3.1% | 10 |
| Jun 2026 | Sudafed | 18.1K | 18% | 1 |
| Jun 2026 | Lemsip | 14.8K | 14.7% | 2 |
| Jun 2026 | Strepsils | 14.8K | 14.7% | 3 |
| Jun 2026 | Bisolvon | 9.9K | 9.9% | 4 |
| Jun 2026 | Codral | 9.9K | 9.9% | 5 |
| Jun 2026 | Demazin | 8.1K | 8.1% | 6 |
| Jun 2026 | Vicks | 8.1K | 8.1% | 7 |
| Jun 2026 | Difflam | 6.6K | 6.6% | 8 |
| Jun 2026 | Duro-Tuss | 6.6K | 6.6% | 9 |
| Jun 2026 | Nurofen | 3.6K | 3.6% | 10 |
| Jul 2026 | Sudafed | 22.2K | 20.6% | 1 |
| Jul 2026 | Strepsils | 18.1K | 16.8% | 2 |
| Jul 2026 | Lemsip | 14.8K | 13.7% | 3 |
| Jul 2026 | Bisolvon | 9.9K | 9.2% | 4 |
| Jul 2026 | Codral | 9.9K | 9.2% | 5 |
| Jul 2026 | Demazin | 8.1K | 7.5% | 6 |
| Jul 2026 | Vicks | 8.1K | 7.5% | 7 |
| Jul 2026 | Difflam | 6.6K | 6.1% | 8 |
| Jul 2026 | Duro-Tuss | 6.6K | 6.1% | 9 |
| Jul 2026 | Nurofen | 3.6K | 3.3% | 10 |
| Aug 2026 | Sudafed | 22.2K | 20.1% | 1 |
| Aug 2026 | Strepsils | 18.1K | 16.4% | 2 |
| Aug 2026 | Lemsip | 14.8K | 13.4% | 3 |
| Aug 2026 | Bisolvon | 9.9K | 9% | 4 |
| Aug 2026 | Codral | 9.9K | 9% | 5 |
| Aug 2026 | Demazin | 8.1K | 7.4% | 6 |
| Aug 2026 | Difflam | 8.1K | 7.4% | 7 |
| Aug 2026 | Vicks | 8.1K | 7.4% | 8 |
| Aug 2026 | Duro-Tuss | 6.6K | 6% | 9 |
| Aug 2026 | Nurofen | 4.4K | 4% | 10 |
| Sep 2026 | Strepsils | 18.1K | 17% | 1 |
| Sep 2026 | Sudafed | 18.1K | 17% | 2 |
| Sep 2026 | Lemsip | 14.8K | 13.9% | 3 |
| Sep 2026 | Bisolvon | 9.9K | 9.3% | 4 |
| Sep 2026 | Codral | 9.9K | 9.3% | 5 |
| Sep 2026 | Demazin | 9.9K | 9.3% | 6 |
| Sep 2026 | Vicks | 8.1K | 7.6% | 7 |
| Sep 2026 | Difflam | 6.6K | 6.2% | 8 |
| Sep 2026 | Duro-Tuss | 6.6K | 6.2% | 9 |
| Sep 2026 | Nurofen | 4.4K | 4.1% | 10 |

## What is being compared

- **Bisolvon**: Measured on the search term “bisolvon”.
- **Codral**: Measured on the search term “codral”.
- **Demazin**: Measured on the search term “demazin”.
- **Difflam**: Measured on the search term “difflam”.
- **Duro-Tuss**: Measured on the search term “duro tuss”.
- **Lemsip**: Measured on the search term “lemsip”.
- **Nurofen**: Measured on the search term “nurofen cold and flu”.
- **Strepsils**: Measured on the search term “strepsils”.
- **Sudafed**: Measured on the search term “sudafed”.
- **Vicks**: Measured on the search term “vicks”.

- [Bisolvon](/demand/au/brands/bisolvon)
- [Codral](/demand/au/brands/codral)
- [Demazin](/demand/au/brands/demazin)
- [Difflam](/demand/au/brands/difflam)
- [Duro-Tuss](/demand/au/brands/duro-tuss)
- [Lemsip](/demand/au/brands/lemsip)
- [Nurofen](/demand/au/brands/nurofen)
- [Strepsils](/demand/au/brands/strepsils)
- [Sudafed](/demand/au/brands/sudafed)
- [Vicks](/demand/au/brands/vicks)

## Methodology

- [How is the Brand Demand Index measured?](/demand/methodology): Where the figures come from, what they compare, and how they may be reused.

## Frequently asked questions

### Which brand is most popular in search among cold and flu brands in Australia?

Strepsils and Sudafed tie for the highest share of searches among cold and flu brands in Australia, at 17% each in September 2026.

## Cite this page

Brandwave. "Cold and flu brands in Australia: Which are searched most?". https://gobrandwave.com/demand/au/categories/au-cold-and-flu-brands

This page is also available as HTML at https://gobrandwave.com/demand/au/categories/au-cold-and-flu-brands. Brandwave publishes an index of its Markdown pages at https://gobrandwave.com/llms.txt.